E. Ohman J:or Asset Management AB

Source: SEC Form 13F · as of Mar 2026

E. Ohman J:or Asset Management AB holds 45 biotech & pharma companies tracked by BioSniper, totaling $221.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

45

Total value held

$221.4M

CompanySharesValue
GILDGILEAD SCIENCES, INC.382,002$53.2M
LLYELI LILLY & Co27,497$25.3M
CYTKCYTOKINETICS INC300,762$19.8M
JNJJOHNSON & JOHNSON57,284$14.0M
ABBVAbbVie Inc.60,112$13.1M
MRKMerck & Co., Inc.85,057$10.2M
UNHUnitedHealth Group Incorporated Common Stock (DE)30,779$8.3M
AMGNAMGEN INC18,385$6.5M
ABTABBOTT LABORATORIES58,437$6.0M
PFEPFIZER INC199,117$5.6M
MCKMcKesson Corporation5,691$4.9M
BMYBRISTOL MYERS SQUIBB CO69,612$4.2M
VRTXVERTEX PHARMACEUTICALS INC / MA8,823$3.9M
RGENREPLIGEN CORP28,600$3.4M
TARSTarsus Pharmaceuticals, Inc.42,087$3.0M
LNTHLantheus Holdings, Inc.36,937$2.8M
GMOptec International, Inc.37,070$2.8M
OCULOCULAR THERAPEUTIX, INC300,000$2.5M
CORCencora Inc.7,980$2.5M
ELVElevance Health Inc.8,297$2.4M
ZTSZoetis Inc.20,414$2.4M
REGNREGENERON PHARMACEUTICALS, INC.2,840$2.2M
CAHCardinal Health Inc.10,319$2.2M
IDXXIDEXX LABORATORIES INC /DE3,521$2.0M
VERAVera Therapeutics, Inc.42,990$1.7M
ARRYARRAY BIOPHARMA INC233,035$1.7M
ALNYALNYLAM PHARMACEUTICALS, INC.4,584$1.5M
IQVIQVIA Holdings Inc.7,361$1.3M
TERNTerns Pharmaceuticals, Inc.22,152$1.2M
WSTWest Pharmaceutical Services Inc.4,465$1.1M
SRRKScholar Rock Holding Corp22,136$1.1M
GEHCGE HealthCare Technologies Inc.15,021$1.1M
UTHRUNITED THERAPEUTICS Corp1,521$902K
BIIBBIOGEN INC.4,819$883K
INSMINSMED Inc5,239$857K
DGXQuest Diagnostics Incorporated3,950$774K
TEVATeva Pharmaceutical Industries Limited19,680$593K
ZBHZimmer Biomet Holdings Inc.6,506$588K
RDYDR REDDYS LABORATORIES LTD40,000$554K
INCYIncyte Corp.5,413$509K
NBIXNEUROCRINE BIOSCIENCES INC3,512$463K
VKTXViking Therapeutics, Inc.12,116$394K
RVMDREVOLUTION MEDICINES, INC.4,000$389K
RYTMRHYTHM PHARMACEUTICALS, INC.4,409$383K
GPCRStructure Therapeutics Inc.4,518$218K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    E. Ohman J:or Asset Management AB — Biotech 13F Holdings & Portfolio | BioSniper